Back to Selection     Print       Date : 30 Apr 2026
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-18
Corpus(Cr.) 6669.0 Latest NAV 41.55 As on 12-06-2026
Equity(%) 96.75 52 Week High 42.07
Debt(%) 3.25 52 Week Low 36.38
Others(%) 0.0 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.41
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 39.49%
Top 10 Holdings 60.15%
Top 25 Holdings 87.67%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 81.9
Healthcare 7.36
Retail 5.09
Cash 3.25
Miscellaneous 1.25
Chemicals 1.15
 
 
 
 
 
Portfolio Metrics
PB Ratio 3.93
PE Ratio 35.21
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.76
Cipla Limited 8.15
Mankind Pharma Limited 7.58
DIVI LABORATORIES LTD 6.06
Dr Reddys Laboratories Limited 5.94
Biocon Limited 5.81
Cohance Lifesciences Limited 4.44
Lupin Limited 3.80
MedPlus Health Services Limited 3.37
Alkem Laboratories Limited 3.24
Syngene International Limited 3.09
TREPS 2.19
Akums Drugs & Pharmaceuticals Ltd. 2.02
Pfizer Limited 1.96
Aurobindo Pharma Limited 1.93
Abbott India Limited 1.88
Thyrocare Technologies Limited 1.88
J B Chemicals and Pharma Ltd 1.77
ALEMBIC PHARMACEUTICALS 1.74
Alivus Life Sciences 1.72
Entero Healthcare Solutions 1.72
Gland Pharma Limited 1.51
Blue Jet Healthcare Limited 1.44
Zydus Lifesciences Limited 1.36
Metropolis Healthcare Limited 1.31

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.81% 10.48% 3.64% 5.54%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
0.09% 2.31% -8.96% -3.41%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-1.19% 6.59% 5.70% 9.27%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
13.26% 26.23% 15.08% 0.00%
 
 
1.41% 9.21% 9.61% 12.64%
 
 
11.76% 23.30% 12.96% 10.95%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 16.84% 1.2568 11.2835% 42.1981 0.1643
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 18.4644% 0.0003 0.3213 14.1156 1.5668
 
Back to Selection